Cellular Dynamics International to Present at 29th Annual JPMorgan Healthcare Conference
MADISON, WIS., Jan. 6, 2011 – Cellular Dynamics International, Inc. (CDI), the world’s largest producer of human induced pluripotent stem (iPS) cell lines and tissue cells for drug discovery and safety, today announced that the company is scheduled to present at the 29th Annual JPMorgan Healthcare Conference at 7:30 a.m. PST, Thursday, January 13, at the Westin St. Francis Hotel in San Francisco. Robert Palay, chief executive officer of CDI, and Emile Nuwaysir, chief operating officer, will provide an overview of the company.
About Cellular Dynamics International, Inc.
Cellular Dynamics International, Inc. (CDI) is a leading developer of stem cell technologies for in vitro drug development, in vivo cellular therapeutics, and stem cell banking. CDI harnesses its unique manufacturing technology to produce differentiated tissue cells in industrial quality, quantity and purity from any individual’s stem cell line created from a standard blood draw. CDI was founded in 2004 by Dr. James Thomson, a pioneer in human pluripotent stem cell research at the University of Wisconsin-Madison. CDI’s facilities are located in Madison, Wisconsin. See www.cellulardynamics.com.